Havrix 720, susp inj 0.5 ml (ancien), ser prê 1 dos

7680005990013 Pharmacode 1829551 CH-599 J07BC02
Havrix 720, susp inj 0.5 ml (ancien), ser prê 1 dos
Havrix 720, susp inj 0.5 ml (ancien), ser prê 1 dos
Havrix 720, susp inj 0.5 ml (ancien), ser prê 1 dos
1 / 3
google

Details

GTIN
7680005990013
Pharmacode
1829551
Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
hepatitis-A-virus inactivatus (HM175)
720.0 U Substance Wirkstoff (Principe actif)
proteina
- Substance WIZUS
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
aluminium
0.25 MG Substance HNIDK
aminoacida
- Substance HNIDK
phenylalaninum
83.0 UG Substance HBESI
dinatrii phosphas
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
- Substance HBESI
kalium
- Substance HNIDK
neomycini sulfas
- Substance HNIDK

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
599
Drug name
Havrix 720, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BC02
Authorization status
Z
Dispensation category
B
First authorization
30/09/1996
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Hepatitis A, ab dem vollendeten 1. bis zum vollendeten 18. Lebensjahr

Packaging details

Description (FR)
HAVRIX 720 susp inj ser pré 0.5 ml
Description (DE)
HAVRIX 720 Inj Susp Fertspr 0.5 ml
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

HAVRIX 720 susp inj (n ser pré) ser pré 0.5 ml
1 FESP
View
Buy us a coffee Explore the data